Literature DB >> 28457023

The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up.

Valérie D V Sankatsing1, Nicolien T van Ravesteyn1, Eveline A M Heijnsdijk1, Caspar W N Looman1, Paula A van Luijt1, Jacques Fracheboud1, Gerard J den Heeten2, Mireille J M Broeders3,2, Harry J de Koning1.   

Abstract

Long-term follow-up data on the effects of screening are scarce, and debate exists on the relative contribution of screening versus treatment to breast cancer mortality reduction. Our aim was therefore to assess the long-term effect of screening by age and time of implementation. We obtained data on 69,630 breast cancer deaths between 1980 and 2010 by municipality (N = 431) and age of death (40-79) in the Netherlands. Breast cancer mortality trends were analyzed by defining the municipality-specific calendar year of introduction of screening as Year 0. Additionally, log-linear Poisson regression was used to estimate the turning point in the trend after Year 0, per municipality, and the annual percentage change (APC) before and after this point. Twenty years after introduction of screening breast cancer mortality was reduced by 30% in women aged 55-74 and by 34% in women aged 75-79, compared to Year 0. A similar and significant decrease was present in municipalities that started early (1987-1992) and late (1995-1997) with screening, despite the difference in availability of effective adjuvant treatment. In the age groups 55-74 and 75-79, the turning point in the trend in breast cancer mortality was estimated in Years 2 and 6 after the introduction of screening, respectively, after which mortality decreased significantly by 1.9% and 2.6% annually. These findings show that the implementation of mammography screening in Dutch municipalities is associated with a significant decline in breast cancer mortality in women aged 55-79, irrespective of time of implementation.
© 2017 UICC.

Entities:  

Keywords:  breast cancer mortality reduction; breast cancer mortality trends; follow-up; full screening coverage; population-based mammography screening

Mesh:

Year:  2017        PMID: 28457023     DOI: 10.1002/ijc.30754

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report.

Authors:  Andrew M McDonald; Yanjun Chen; Jessica Wu; Lindsey Hageman; Liton Francisco; Michelle Kung; F Lennie Wong; Emily Ness; Wendy Landier; Kevin Battles; Donna Salzman; Daniel J Weisdorf; Stephen J Forman; Mukta Arora; Saro H Armenian; Smita Bhatia
Journal:  J Clin Oncol       Date:  2020-07-16       Impact factor: 44.544

2.  Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography.

Authors:  Joost R C Lameijer; Angela Mp Coolen; Adri C Voogd; Luc J Strobbe; Marieke W J Louwman; Dick Venderink; Vivian C Tjan-Heijnen; Lucien E M Duijm
Journal:  Eur Radiol       Date:  2018-04-17       Impact factor: 5.315

3.  Trends in frequency and outcome of high-risk breast lesions at core needle biopsy in women recalled at biennial screening mammography, a multiinstitutional study.

Authors:  Jacky D Luiten; Bram Korte; Adri C Voogd; Willem Vreuls; Ernest J T Luiten; Luc J Strobbe; Matthieu J C M Rutten; Menno L Plaisier; Paul N Lohle; Marianne J H Hooijen; Vivianne C G Tjan-Heijnen; Lucien E M Duijm
Journal:  Int J Cancer       Date:  2019-05-02       Impact factor: 7.396

4.  Factors associated with readmissions in women participating in screening programs and treated for breast cancer: a retrospective cohort study.

Authors:  Carme Miret; Laia Domingo; Javier Louro; Teresa Barata; Marisa Baré; Joana Ferrer; Maria Carmen Carmona-García; Xavier Castells; Maria Sala
Journal:  BMC Health Serv Res       Date:  2019-12-05       Impact factor: 2.655

5.  Effect of screening mammography on breast cancer mortality: Quasi-experimental evidence from rollout of the Dutch population-based program with 17-year follow-up of a cohort.

Authors:  Tom Van Ourti; Owen O'Donnell; Hale Koç; Jacques Fracheboud; Harry J de Koning
Journal:  Int J Cancer       Date:  2019-08-07       Impact factor: 7.396

6.  Frequency and diagnostic outcome of bilateral recall at screening mammography.

Authors:  Joost R C Lameijer; Joost Nederend; Adri C Voogd; Vivianne C G Tjan-Heijnen; Lucien E M Duijm
Journal:  Int J Cancer       Date:  2020-07-17       Impact factor: 7.396

7.  Comparison of the sensitivity of mammography, ultrasound, magnetic resonance imaging and combinations of these imaging modalities for the detection of small (≤2 cm) breast cancer.

Authors:  Hai-Long Chen; Jiao-Qun Zhou; Qiang Chen; Yong-Chuan Deng
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

8.  Comparison of pathological characteristics between self-detected and screen-detected invasive breast cancers in Chinese women: a retrospective study.

Authors:  Qi Zhang; Lanjun Ding; Xuan Liang; Yuan Wang; Jiao Jiao; Wenli Lu; Xiaojing Guo
Journal:  PeerJ       Date:  2018-04-26       Impact factor: 2.984

9.  Delayed breast cancer diagnosis after repeated recall at biennial screening mammography: an observational follow-up study from the Netherlands.

Authors:  Joost R C Lameijer; Adri C Voogd; Ruud M Pijnappel; Wikke Setz-Pels; Mireille J Broeders; Vivianne C G Tjan-Heijnen; Lucien E M Duijm
Journal:  Br J Cancer       Date:  2020-05-11       Impact factor: 7.640

10.  Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark.

Authors:  Elsebeth Lynge; Anna-Belle Beau; My von Euler-Chelpin; George Napolitano; Sisse Njor; Anne Helene Olsen; Walter Schwartz; Ilse Vejborg
Journal:  Breast Cancer Res Treat       Date:  2020-08-30       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.